NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.33
Delayed Data
As of Apr 20
 -0.016 / -0.48%
Today’s Change
2.25
Today|||52-Week Range
5.00
-13.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$49.2M

Company Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in commercializing and developing products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The comapny was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

Contact Information

NovaBay Pharmaceuticals, Inc.
2000 Powell Street
Emeryville California 94608
P:(510) 899-8800
Investor Relations:

Employees

Shareholders

Individual stakeholders59.94%
Other institutional0.42%
Mutual fund holders0.28%

Top Executives

Mark M. SieczkarekChairman, President & Chief Executive Officer
John J. McGovernChief Financial Officer
Justin M. HallSenior Vice President & General Counsel
Lewis J. StuartChief Commercial Officer
Greg MillerDirector-Strategic Sales